The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and central nervous system (CNS) therapies, announced today that the U ...

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...

Stroke remains a leading cause of morbidity worldwide, with limited pharmacological options beyond thrombolysis and thrombectomy in the acute phase. Granulocyte colony-stimulating factor (G-CSF), a ...

The Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) performance improvement methodology was used to implement this formulary conversion project. The key elements of the JCAHO ...

Cluster-randomized trial to evaluate the implementation of reproductive health care in cancer care delivery in community oncology practices: Results from ECOG-ACRIN E1Q11. This is an ASCO Meeting ...